Sarepta Therapeutics (SRPT) Shares Repurchased (2018 - 2025)
Historic Shares Repurchased for Sarepta Therapeutics (SRPT) over the last 9 years, with Q3 2025 value amounting to $16.4 million.
- Sarepta Therapeutics' Shares Repurchased fell 6653.6% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.7 million, marking a year-over-year increase of 5826.93%. This contributed to the annual value of $205.1 million for FY2024, which is 1239.3% up from last year.
- Per Sarepta Therapeutics' latest filing, its Shares Repurchased stood at $16.4 million for Q3 2025, which was down 6653.6% from $41.6 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Shares Repurchased ranged from a high of $205.1 million in Q4 2024 and a low of $16.4 million during Q3 2025
- For the 5-year period, Sarepta Therapeutics' Shares Repurchased averaged around $52.1 million, with its median value being $45.8 million (2023).
- Per our database at Business Quant, Sarepta Therapeutics' Shares Repurchased soared by 34763.45% in 2024 and then plummeted by 6653.6% in 2025.
- Over the past 5 years, Sarepta Therapeutics' Shares Repurchased (Quarter) stood at $29.8 million in 2021, then skyrocketed by 69.6% to $50.5 million in 2022, then fell by 9.27% to $45.8 million in 2023, then surged by 347.63% to $205.1 million in 2024, then tumbled by 92.01% to $16.4 million in 2025.
- Its Shares Repurchased was $16.4 million in Q3 2025, compared to $41.6 million in Q2 2025 and $46.6 million in Q1 2025.